[ad_1]

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 573,798 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was bought at an average price of $1.38 per share, for a total transaction of $791,841.24. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Shares of Corindus Vascular Robotics stock opened at $1.89 on Friday. Corindus Vascular Robotics Inc has a 1 year low of $0.70 and a 1 year high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $4.67 million during the quarter, compared to the consensus estimate of $5.60 million.

Large investors have recently modified their holdings of the stock. Citadel Advisors LLC lifted its position in shares of Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock valued at $164,000 after acquiring an additional 77,829 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Corindus Vascular Robotics in the 4th quarter valued at approximately $64,000. Nomura Holdings Inc. lifted its position in shares of Corindus Vascular Robotics by 18.6% in the 4th quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock valued at $1,077,000 after acquiring an additional 198,111 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Corindus Vascular Robotics in the 4th quarter valued at approximately $36,000. Finally, Millennium Management LLC lifted its position in shares of Corindus Vascular Robotics by 1.0% in the 4th quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock valued at $5,955,000 after acquiring an additional 68,250 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This article was first posted by Fairfield Current and is owned by of Fairfield Current. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.fairfieldcurrent.com/news/2019/03/23/insider-buying-corindus-vascular-robotics-inc-cvrs-director-purchases-791841-24-in-stock.html.

Corindus Vascular Robotics Company Profile

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Featured Article: Dividend Aristocrat Index

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

Source link